Literature DB >> 30228726

Peptic Ulcer Disease and Helicobacter pylori infection.

Mechu Narayanan1, Kavya M Reddy2, Elizabeth Marsicano3.   

Abstract

Peptic ulcer disease (PUD) is a common condition that both primary care providers and gastroenterologists encounter. Symptoms of peptic ulcer disease are variable and may include abdominal pain, nausea, vomiting, weight loss and bleeding or perforation with complicated disease. Identifying the risk factors and mechanisms that lead to the development of PUD helps to understand the approach behind diagnostic and treatment strategies.

Entities:  

Mesh:

Year:  2018        PMID: 30228726      PMCID: PMC6140150     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  33 in total

1.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 2.  Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.

Authors:  George-V Papatheodoridis; Athanasios-J Archimandritis
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.

Authors:  S Somasundaram; G Sigthorsson; R J Simpson; J Watts; M Jacob; I A Tavares; S Rafi; A Roseth; R Foster; A B Price; J M Wrigglesworth; I Bjarnason
Journal:  Aliment Pharmacol Ther       Date:  2000-05       Impact factor: 8.171

4.  Helicobacter-negative gastritis: polymerase chain reaction for Helicobacter DNA is a valuable tool to elucidate the diagnosis.

Authors:  S Kiss; V Zsikla; A Frank; N Willi; G Cathomas
Journal:  Aliment Pharmacol Ther       Date:  2016-02-17       Impact factor: 8.171

5.  Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities.

Authors:  Yonatan H Grad; Marc Lipsitch; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2011-11-15       Impact factor: 4.897

Review 6.  Risk of gastrointestinal bleeding during anticoagulant treatment.

Authors:  Aitor Lanas-Gimeno; Angel Lanas
Journal:  Expert Opin Drug Saf       Date:  2017-05-17       Impact factor: 4.250

7.  Risk of upper gastrointestinal bleeding from different drug combinations.

Authors:  Gwen M C Masclee; Vera E Valkhoff; Preciosa M Coloma; Maria de Ridder; Silvana Romio; Martijn J Schuemie; Ron Herings; Rosa Gini; Giampiero Mazzaglia; Gino Picelli; Lorenza Scotti; Lars Pedersen; Ernst J Kuipers; Johan van der Lei; Miriam C J M Sturkenboom
Journal:  Gastroenterology       Date:  2014-06-14       Impact factor: 22.682

8.  Transfusion strategies for acute upper gastrointestinal bleeding.

Authors:  Càndid Villanueva; Alan Colomo; Alba Bosch; Mar Concepción; Virginia Hernandez-Gea; Carles Aracil; Isabel Graupera; María Poca; Cristina Alvarez-Urturi; Jordi Gordillo; Carlos Guarner-Argente; Miquel Santaló; Eduardo Muñiz; Carlos Guarner
Journal:  N Engl J Med       Date:  2013-01-03       Impact factor: 91.245

9.  Value of the "Test & Treat" Strategy for Uninvestigated Dyspepsia at Low Prevalence Rates of Helicobacter pylori in the Population.

Authors:  Lars Agréus; Nicholas J Talley; Michael Jones
Journal:  Helicobacter       Date:  2015-09-08       Impact factor: 5.753

10.  Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis.

Authors:  Antonio González-Pérez; María E Sáez; Saga Johansson; Péter Nagy; Luis A García Rodríguez
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more
  28 in total

1.  Assessing the Need for Proton Pump Inhibitors for Patients Using Long-Term Nonsteroidal Anti-inflammatory Drugs without a History of Ulcers.

Authors:  Kevin Kwok; Aaron Tejani
Journal:  Can J Hosp Pharm       Date:  2020-06-01

2.  [Combined detection of Helicobacter pylori 16S rRNA and cagA gene in saliva specimens using multiplex PCR].

Authors:  X Wang; L Sun; Z Yang; S Song; N Li; Y Liu; W Tian; Y Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

3.  Risk Factors for Recurrence of Peptic Ulcer Disease: A Retrospective Study in Tertiary Care Referral Center.

Authors:  Yaser M Alsinnari; Mohammed S Alqarni; Meshari Attar; Ziad M Bukhari; Mohammed Almutairi; Faisal M Baabbad; Mohammed Hasosah
Journal:  Cureus       Date:  2022-02-07

4.  Bioinformatics analysis of adhesin-binding potential and ADME/Tox profile of anti-Helicobacter pylori peptides derived from wheat germ proteins.

Authors:  Chi Dang; Ogadimma Okagu; Xiaohong Sun; Chibuike C Udenigwe
Journal:  Heliyon       Date:  2022-06-03

5.  Sea urchins: an update on their pharmacological properties.

Authors:  Dulce María Moreno-García; Deyanira Ojeda-Ramírez; Monica Salas-Rojas; Eduardo Fernández-Martínez; Ma Del Rocío López-Cuellar; Carolina G Sosa-Gutierrez; Armando Peláez-Acero; Nallely Rivero-Perez; Adrian Zaragoza-Bastida
Journal:  PeerJ       Date:  2022-07-04       Impact factor: 3.061

6.  Helicobacter pylori infection in non-ulcer dyspepsia: A cross-sectional study.

Authors:  P K Sharma; S Salaria; M Manrai; S Srivastava; D Kumar; A R Singh
Journal:  Med J Armed Forces India       Date:  2021-02-27

Review 7.  Alternative Treatments for Minor GI Ailments.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-07-05

8.  Effect of a Cytoprotective Dose of Dehydroleucodine, Xanthatin, and 3-Benzyloxymethyl-5H-furan-2-one on Gastric Mucosal Lesions Induced by Mast Cell Activation.

Authors:  Mariano Ezequiel Vera; María Laura Mariani; Cristina Aguilera; Alicia Beatriz Penissi
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

9.  Functionally significant polymorphisms of the MMP-9 gene are associated with peptic ulcer disease in the Caucasian population of Central Russia.

Authors:  Oksana Minyaylo; Irina Ponomarenko; Evgeny Reshetnikov; Volodymyr Dvornyk; Mikhail Churnosov
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Cannabis Use Disorders Lead to Hospitalizations for Peptic Ulcer Disease: Insights From a Nationwide Inpatient Sample Analysis.

Authors:  Hajara Joundi; Kristal N Pereira; Goher Haneef; Renu Bhandari; Jannat Malik; Rushi P Shah; Albulena Sejdiu; Keerthika Mathialagan
Journal:  Cureus       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.